Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Simioni

Showing results (51-60 of 161) with videos related to

Pageof 17
Sort By:
Journal of Thrombosis and Thrombolysis|November 6, 2023
Mesoglycan for the secondary prevention of superficial vein thrombosis: a randomized, controlled, double-blind study (METRO Study)-rationale and protocolG Camporese, E Bernardi, C Bortoluzzi, et al.
Blood Reviews|May 23, 1998
Hemorrhagic and thrombotic disorders due to factor V deficiencies and abnormalities: an updated classificationA Girolami, P Simioni, L Scarano, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Asymptomatic homozygous nt 20210 G to A prothrombin polymorphism in two blood donors belonging to two different kindredsA Girolami, P Simioni, D Manfrin, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 24, 1998
Factor V variants, activated protein C resistance and venous thromboembolismP Simioni, M Kalafatis, D Manfrin, et al.
Seminars in Vascular Medicine|June 17, 2004
Postthrombotic syndrome: incidence, prevention, and managementE Bernardi, P Bagatella, M Frulla, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 1, 1997
Factor V antigen levels in APC resistance, in factor V deficiency and in combined APC resistance and factor V deficiency (pseudohomozygosis for APC resistance)A Girolami, P Simioni, U Venturelli, et al.
Journal of Thrombosis and Haemostasis : JTH|November 6, 2008
Duration of anticoagulation and risk of recurrent thromboembolism in carriers of factor V Leiden or prothrombin mutationP Prandoni, D Tormene, L Spiezia, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1987
Factor X antigen--factor X activity discrepancy in coumarin treated patients. No relationship with dilution curveA Girolami, M G Cappellato, A R Lazzaro, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 10, 2000
Clinical and laboratory expression of associated thrombophilic conditions (homozygous/heterozygous factor V Leiden mutation and heterozygous prothrombin variant 20210A) in an Italian familyP Simioni, D Tormene, S Luni, et al.
Journal of Thrombosis and Thrombolysis|March 23, 2000
Symptomatic combined homozygous factor XII deficiency and heterozygous factor V Leiden. luscaber@tin.itA Girolami, P Simioni, L Scarano, et al.
Pageof 17

Showing results (51-60 of 161) with videos related to

Sort By:
Pageof 17
Journal of Thrombosis and Thrombolysis|November 6, 2023
Mesoglycan for the secondary prevention of superficial vein thrombosis: a randomized, controlled, double-blind study (METRO Study)-rationale and protocolG Camporese, E Bernardi, C Bortoluzzi, et al.
Blood Reviews|May 23, 1998
Hemorrhagic and thrombotic disorders due to factor V deficiencies and abnormalities: an updated classificationA Girolami, P Simioni, L Scarano, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Asymptomatic homozygous nt 20210 G to A prothrombin polymorphism in two blood donors belonging to two different kindredsA Girolami, P Simioni, D Manfrin, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 24, 1998
Factor V variants, activated protein C resistance and venous thromboembolismP Simioni, M Kalafatis, D Manfrin, et al.
Seminars in Vascular Medicine|June 17, 2004
Postthrombotic syndrome: incidence, prevention, and managementE Bernardi, P Bagatella, M Frulla, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 1, 1997
Factor V antigen levels in APC resistance, in factor V deficiency and in combined APC resistance and factor V deficiency (pseudohomozygosis for APC resistance)A Girolami, P Simioni, U Venturelli, et al.
Journal of Thrombosis and Haemostasis : JTH|November 6, 2008
Duration of anticoagulation and risk of recurrent thromboembolism in carriers of factor V Leiden or prothrombin mutationP Prandoni, D Tormene, L Spiezia, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1987
Factor X antigen--factor X activity discrepancy in coumarin treated patients. No relationship with dilution curveA Girolami, M G Cappellato, A R Lazzaro, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 10, 2000
Clinical and laboratory expression of associated thrombophilic conditions (homozygous/heterozygous factor V Leiden mutation and heterozygous prothrombin variant 20210A) in an Italian familyP Simioni, D Tormene, S Luni, et al.
Journal of Thrombosis and Thrombolysis|March 23, 2000
Symptomatic combined homozygous factor XII deficiency and heterozygous factor V Leiden. luscaber@tin.itA Girolami, P Simioni, L Scarano, et al.
Pageof 17